Article info

Download PDFPDF
Letter
Benefit versus toxicity risk of digoxin in patients with COVID-19

Authors

  1. Correspondence to Mrs Burcu Kelleci Cakir, Department of Clinical Pharmacy, Hacettepe University Faculty of Pharmacy, 06100 Ankara, Turkey; burcukelleci{at}hacettepe.edu.tr
View Full Text

Citation

Kelleci Cakir B, Bayraktar-Ekincioglu A, Demirkan K
Benefit versus toxicity risk of digoxin in patients with COVID-19

Publication history

  • First published June 2, 2021.
Online issue publication 
October 25, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.